Sleeve gastrectomy (SG), as a standalone bariatric procedure, has shown remarkable results with respect to weight reduction and the amelioration of obesity-associated comorbid conditions. Over the past two decades, its acceptance has surged exponentially among bariatric surgeons and patients. Nevertheless, postoperative hemorrhage originating from the staple line remains a notable complication. The prevalence of postoperative hemorrhage subsequent to laparoscopic sleeve gastrectomy (LSG) varies between 1% and 6% (Melissas et al., Obes Surg 17:57–62, 2007; Frezza, Surg Today 37:275–281, 2007). This highlights the need for effective hemostatic strategies to mitigate the risk caused by this surgery.